MiniQES Platform

With a small footprint, a very simple operation, minimal sample requirements, and powerful analytics, the MiniQES Platform enables sample processing where the sample is collected, without sacrificing content or robustness.

Biomarker and target discovery of type II diabetes in small animals

Starting with a limited set of samples and metadata for training (diseased versus control animals), a phenotype of type II diabetes was defined and led to the discovery of potential new biomarkers and therapeutic targets for the disease. 


  • Whole blood from C57BL/6 mice – 2uL volume
  • 100% specificity and 100% sensitivity on sample classification using Probius signature and biomarker network
  • A posteriori analysis of disease pathways involving immune response and glucose and fatty acid metabolism

To request the full case study please use our contact form.

MiniQES Platform

With a small footprint, a very simple operation, minimal sample requirements, and powerful analytics, the MiniQES Platform enables the collection and processing of samples closer to the source without sacrificing content or robustness.